Vaxman, Iuliana http://orcid.org/0000-0002-8390-064X
Sidiqi, M. Hasib
Al Saleh, Abdullah S.
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Dispenzieri, Angela http://orcid.org/0000-0001-8780-9512
Buadi, Francis
Dingli, David
Lacy, Martha
Hayman, Suzanne
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Gonsalves, Wilson
Kourelis, Taxiarchis
Warsame, Rahma
Hogan, William http://orcid.org/0000-0002-5841-4105
Gertz, Morie http://orcid.org/0000-0002-3853-5196
Article History
Received: 28 April 2020
Revised: 25 August 2020
Accepted: 3 November 2020
First Online: 18 November 2020
Compliance with ethical standards
:
: Dr. Gertz reports personal fees from Ionis/Akcea, personal fees from Alnylam, personal fees from Prothena, personal fees from Celgene, personal fees from Janssen, grants and personal fees from Spectrum, personal fees from Annexon, personal fees from Appellis, personal fees from Amgen, personal fees from Medscape, personal fees from Physicians Education Resource, personal fees for Data Safety Monitoring board from Abbvie, personal fees from Research to Practice, speaker fees from Teva, Speaker fees from Johnson and Johnson; Speaker fees from Medscape, Speaker fees DAVA oncology; Advisory Board for Pharmacyclics Advisory Board for Proclara outside the submitted work; Development of educational materials for i3Health, Educational Program development i3Health, Royalties from Springer Publishing, Grant Funding Amyloidosis Foundation; International Waldenstrom Foundation. The authors declare that they have no conflict of interest.